Core One Labs Inc (CLABF)
0.1072
-0.01
(-9.92%)
USD |
OTCM |
Jun 21, 14:48
Core One Labs Total Liabilities (Quarterly): 1.326M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.326M |
| September 30, 2023 | 1.068M |
| September 30, 2022 | 1.142M |
| June 30, 2022 | 1.696M |
| March 31, 2022 | 2.485M |
| December 31, 2021 | 2.589M |
| September 30, 2021 | 2.827M |
| June 30, 2021 | 2.988M |
| March 31, 2021 | 2.944M |
| December 31, 2020 | 3.240M |
| September 30, 2020 | 9.762M |
| June 30, 2020 | 9.826M |
| March 31, 2020 | 10.19M |
| December 31, 2019 | 9.328M |
| September 30, 2019 | 4.112M |
| June 30, 2019 | 3.701M |
| March 31, 2019 | 3.631M |
| December 31, 2018 | 3.511M |
| September 30, 2018 | 0.7588M |
| June 30, 2018 | 0.7566M |
| March 31, 2018 | 1.69M |
| December 31, 2017 | 1.783M |
| June 30, 2017 | 0.4343M |
| March 31, 2017 | 0.3222M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.1881M |
| September 30, 2016 | 0.5614M |
| June 30, 2016 | 0.5898M |
| March 31, 2016 | 0.417M |
| December 31, 2015 | 0.2708M |
| September 30, 2015 | 0.3147M |
| June 30, 2015 | 0.2155M |
| March 31, 2015 | 0.3775M |
| December 31, 2014 | 0.3459M |
| September 30, 2014 | 0.5316M |
| June 30, 2014 | 0.4452M |
| March 31, 2014 | 0.0289M |
| December 31, 2013 | 0.0016M |
| September 30, 2013 | 0.0451M |
| June 30, 2013 | 0.0482M |
| March 31, 2013 | 0.0592M |
| December 31, 2012 | 0.0236M |
| September 30, 2012 | 0.0119M |
| June 30, 2012 | 0.0239M |
| March 31, 2012 | 0.0219M |
| December 31, 2011 | 0.0024M |
| September 30, 2011 | 0.0232M |
| June 30, 2011 | 0.0497M |
| March 31, 2011 | 0.0323M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.068M
Minimum
Sep 2023
10.19M
Maximum
Mar 2020
4.326M
Average
2.966M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| InMed Pharmaceuticals Inc | 2.254M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.578M |
| Shareholders Equity (Quarterly) | 4.252M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 0.2534 |
| Net Debt Paydown Yield | -0.29% |